Spain debates regulation of private cord cell banks:
This article was originally published in Clinica
The Spanish Senate is today debating a motion urging the government to ensure the tightest regulation of private umbilical cord cell banks, in line with the safety and other norms set out under EU legislation. The government is preparing to regulate the authorisation and operational standards of such centres and the trade in placental and cord blood,through its transposition of the EU tissue and cells directive (2004/23/CE). This will, in turn, update Spanish legislation dating back to 1996. Last week, health minister Elena Salgado divulged an outline of the draft. The initiative of the opposition socialist party (PSOE) also seeks to formalise the "altruistic donation" of such tissues, by ensuring that public cell banks are used as the "preferred option".
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.